Focussed on uncovering every skincare story
Alsys Research Inc. is an early commercial-stage medical dermatology company that champions meaningful innovation to address the urgent needs of individuals living with immune-mediated dermatological diseases and conditions. With a commitment to solving the most persistent patient challenges in dermatology, Alsys has a growing portfolio that harnesses our unique dermatology development platform coupled with our dermatology expertise to build differentiated therapies against biologically validated targets.
Alsys dermatology development platform includes a robust pipeline with multiple clinical programs for a range of inflammatory dermatological conditions including scalp and body psoriasis, atopic dermatitis, seborrheic dermatitis, and alopecia areata.
Our mission is to develop and deliver innovative skincare compounds to address problems in public health and improve the lives of people across the world.
Investor resources
FAQs
Why collaborate?
PRC0028, the bioactive extract and Alsys’ first-line TOPICAL treatment for Psoriasis in the world is ready to be explored.
Before
After
Before
After
Events & presentations
Upcoming events and
latest webcast
View all upcoming and past events.
Join Our Newsletter
Reportedly, psoriasis is a global problem with at least 125 million individuals affected worldwide, with no definite cure…